Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 390.00
+0.50 (0.13%)
Oct 31, 2025, 2:31 PM CST
Sunmax Biotechnology Revenue
Sunmax Biotechnology had revenue of 460.13M TWD in the quarter ending June 30, 2025, with 1.42% growth. This brings the company's revenue in the last twelve months to 1.95B, up 10.87% year-over-year. In the year 2024, Sunmax Biotechnology had annual revenue of 1.82B with 7.64% growth.
Revenue (ttm)
1.95B
Revenue Growth
+10.87%
P/S Ratio
10.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.82B | 129.03M | 7.64% |
| Dec 31, 2023 | 1.69B | 288.91M | 20.64% |
| Dec 31, 2022 | 1.40B | 364.42M | 35.19% |
| Dec 31, 2021 | 1.04B | 179.81M | 21.01% |
| Dec 31, 2020 | 855.85M | 261.71M | 44.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |